Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Goel

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Journal of Cardiothoracic and Vascular Anesthesia|December 4, 2004
Case 5--2004: Transesophageal echocardiography-guided insertion of a pulmonary artery catheterDeepak K Tempe, Vishnu Datt, Amit Banerjee, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2005
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumorsWilliam C Zamboni, Sanjay Goel, Tahir Iqbal, et al.
Investigational New Drugs|December 3, 2015
Phase I, dose-escalating study of elisidepsin (Irvalec(®)), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumorsSanjay Goel, Santiago Viteri, Teresa Morán, et al.
Journal of Gastrointestinal Cancer|November 3, 2019
The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic CancerMichael Shusterman, Erin Jou, Andreas Kaubisch, et al.
JAMA Network Open|July 11, 2024
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-AnalysisSanjay Goel, Abdissa Negassa, Mohammad H Ghalib, et al.
International Journal of Molecular Sciences|November 27, 2019
Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal CancerRadhashree Maitra, Thongthai Thavornwatanayong, Madhu Kumar Venkatesh, et al.
Cancer|July 30, 2024
Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of lifeLogin S George, Paul R Duberstein, Nancy L Keating, et al.
Clinical Colorectal Cancer|January 31, 2012
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancerArjun Sood, Danielle McClain, Radhashree Maitra, et al.
Investigational New Drugs|May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancersSanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Canadian Journal of Gastroenterology & Hepatology|December 12, 2018
Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma PatientsJustin Y Tang, Nitin Ohri, Rafi Kabarriti, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Journal of Cardiothoracic and Vascular Anesthesia|December 4, 2004
Case 5--2004: Transesophageal echocardiography-guided insertion of a pulmonary artery catheterDeepak K Tempe, Vishnu Datt, Amit Banerjee, et al.
Cancer Chemotherapy and Pharmacology|October 6, 2005
Clinical and pharmacokinetic study evaluating the effect of food on the disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in patients with solid tumorsWilliam C Zamboni, Sanjay Goel, Tahir Iqbal, et al.
Investigational New Drugs|December 3, 2015
Phase I, dose-escalating study of elisidepsin (Irvalec(®)), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumorsSanjay Goel, Santiago Viteri, Teresa Morán, et al.
Journal of Gastrointestinal Cancer|November 3, 2019
The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in An Ethnically Diverse Patient Population with Advanced Pancreatic CancerMichael Shusterman, Erin Jou, Andreas Kaubisch, et al.
JAMA Network Open|July 11, 2024
Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials: A Meta-AnalysisSanjay Goel, Abdissa Negassa, Mohammad H Ghalib, et al.
International Journal of Molecular Sciences|November 27, 2019
Development and Characterization of a Genetic Mouse Model of KRAS Mutated Colorectal CancerRadhashree Maitra, Thongthai Thavornwatanayong, Madhu Kumar Venkatesh, et al.
Cancer|July 30, 2024
Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of lifeLogin S George, Paul R Duberstein, Nancy L Keating, et al.
Clinical Colorectal Cancer|January 31, 2012
PTEN gene expression and mutations in the PIK3CA gene as predictors of clinical benefit to anti-epidermal growth factor receptor antibody therapy in patients with KRAS wild-type metastatic colorectal cancerArjun Sood, Danielle McClain, Radhashree Maitra, et al.
Investigational New Drugs|May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancersSanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Canadian Journal of Gastroenterology & Hepatology|December 12, 2018
Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma PatientsJustin Y Tang, Nitin Ohri, Rafi Kabarriti, et al.
Pageof 19